Streetbeat News

Stock Prices

RIVN

Rivian's stock price has declined following the release of their 2023 delivery and production numbers, which investors may have found disappointing.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 3:02 pm

MRNA

Moderna's stock (MRNA) is experiencing an uptick following an upgrade from Perform to Outperform by Oppenheimer. This positive analyst rating change suggests increased confidence in the company's future performance and may influence investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 3:01 pm

SOLUSD

Solana (CRYPTO: SOL) has seen a 5.12% price increase over the past 24 hours, reaching $109.78, despite a 2.0% decline over the past week from $113.23. The coin is below its all-time high of $259.96. Trading volume has decreased by 40.0% over the past week, correlating with a slight 0.03% drop in circulating supply, now at 430.02 million. Solana's market cap is currently ranked #5 at $47.57 billion.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 3:01 pm

MSFT

Piper Sandler analyst Brent Bracelin has maintained an Overweight rating on Microsoft (NASDAQ:MSFT) and increased the price target from $425 to $455.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 3:01 pm

CNC

Analysts have varied opinions on Centene (NYSE:CNC), with recent ratings ranging from bullish to bearish. The average 12-month price target for CNC is $83.00, with a high of $90.00 and a low of $74.00, reflecting a 6.41% increase from the previous target of $78.00. Notable analysts from firms like Wells Fargo, Truist Securities, UBS, Cantor Fitzgerald, and Jefferies have updated their ratings and price targets, with most raising their targets except for Jefferies, which lowered its target from $82.00 to $81.00. Centene's financial performance shows solid revenue growth but below-average net margins and a high debt-to-equity ratio, although it has an impressive ROE and ROA.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 3:00 pm

COST

Benzinga's options scanner identified unusual options activity for Costco Wholesale (NASDAQ:COST), with a bullish sentiment from big-money traders. Eleven atypical options trades were detected, with 8 calls totaling $1,000,102 and 3 puts at $284,000. Whales target a price range of $485.0 to $685.0 for COST over the next 3 months. The stock is slightly down with a potential overbought RSI. Analysts maintain ratings from Buy to Neutral with price targets ranging from $600 to $741. Options trading carries risks and requires ongoing education and market awareness.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 3:00 pm

BTCUSD

Bitcoin (BTC) has seen a significant increase of 6.06% in the past 24 hours, reaching a price of $45,203.00. Over the last week, it has gained 7.0%, rising from $42,592.36. Despite this growth, it remains below its all-time high of $69,045.00. The trading volume has increased by 21.0% over the past week, while the circulating supply has slightly decreased by 0.18% to 19.59 million coins, which is 93.27% of the maximum supply. Bitcoin currently holds the #1 market cap ranking at $888.67 billion.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 3:00 pm

POL

Shares of Polished (POL) were halted on a circuit breaker due to a rapid increase in price, with the stock currently up 36%.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 2:57 pm

LBPH

Longboard Pharmaceuticals Inc (NASDAQ:LBPH) reported positive topline data from the PACIFIC Phase 1b/2a study of bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs). The study showed a significant reduction in seizure frequency compared to placebo, with favorable safety and tolerability results. Following the news, LBPH stock soared over 200%, trading at $17.52.

Portfolio Pulse from Vandana Singh

January 02, 2024 | 2:56 pm

LBPH

Cantor Fitzgerald analyst Josh Schimmer has maintained an Overweight rating on Longboard Pharmaceuticals (LBPH) and increased the price target from $35 to $55.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 2:55 pm